Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

HAROLD J MILLER

Allopathic & Osteopathic Physicians Internal Medicine Endocrinology, Diabetes & Metabolism

NPI
1295707669
CMS profile
330226
Location
HAMMOND, LA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$10,858.18

245 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

Page 2 of 5; records 51–100 of 245 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

HAROLD J MILLER

NPI 1295707669 · CMS profile ID 330226

Allopathic & Osteopathic Physicians / Internal Medicine / Endocrinology, Diabetes & Metabolism

HAMMOND, LA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 5; records 51–100 of 245 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1295707669?year=2021&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
HAROLD J MILLER, NPI 1295707669, CMS profile ID 330226. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 5; records 51–100 of 245 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1295707669?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). HAROLD J MILLER, NPI 1295707669, CMS profile ID 330226. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 5; records 51–100 of 245 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1295707669?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
HAROLD J MILLER, NPI 1295707669, CMS profile ID 330226, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 5; records 51–100 of 245 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1295707669?year=2021&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

245 matching records · $10,858.18 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 245 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 245.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Abbott Laboratories $8.2510/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815724235 CMS
Abbott Laboratories $19.7510/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815724239 CMS
Abbott Laboratories $127.7510/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815724243 CMS
Novo Nordisk Inc $22.8910/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 810671211 CMS
Amarin Pharma Inc. $19.2610/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815386695 CMS
Bayer HealthCare Pharmaceuticals Inc. $12.1210/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 789066913 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $18.4410/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 850177071 CMS
GRT US Holding, Inc. $22.9510/02/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 841338393 CMS
Amgen Inc. $16.6309/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825346547 CMS
Corcept Therapeutics $24.6609/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 837533265 CMS
IBSA Pharma Inc. $17.1709/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 792512155 CMS
Lilly USA, LLC $16.3009/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 819117957 CMS
Xeris Pharmaceuticals, Inc. $21.2709/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 837435595 CMS
SANOFI-AVENTIS U.S. LLC $15.1009/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843484741 CMS
Medtronic, Inc. $10.0409/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 827391417 CMS
Medtronic, Inc. $12.7209/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 827391419 CMS
DEXCOM, INC. $22.3609/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845289659 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $8.9809/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 850092813 CMS
Amarin Pharma Inc. $19.5209/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815045098 CMS
AbbVie Inc. $16.1109/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795687389 CMS
LifeScan, Inc. $17.9509/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845333629 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $16.8509/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 849997435 CMS
Abbott Laboratories $18.4708/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 833793759 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $17.8608/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 849980283 CMS
Corcept Therapeutics $25.0008/28/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 837533281 CMS
AstraZeneca Pharmaceuticals LP $14.2408/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829795929 CMS
Corcept Therapeutics $12.6008/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 837533279 CMS
Corcept Therapeutics $66.0008/25/2021 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 837533275 CMS
Corcept Therapeutics $8.3608/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 837533277 CMS
Lilly USA, LLC $24.9208/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 819083565 CMS
Lilly USA, LLC $13.2408/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 819183539 CMS
AbbVie Inc. $12.9808/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795687383 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $15.7708/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 850247841 CMS
Amgen Inc. $23.2108/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 825346543 CMS
DEXCOM, INC. $9.3908/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845289657 CMS
Lilly USA, LLC $15.8008/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 818562397 CMS
LifeScan, Inc. $21.9208/18/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 845333283 CMS
AstraZeneca Pharmaceuticals LP $12.5108/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 829845017 CMS
Novo Nordisk Inc $16.8808/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 811192689 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $12.4108/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 850218577 CMS
AbbVie Inc. $14.0508/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795687377 CMS
MannKind Corporation $20.3408/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 821069935 CMS
Clarus Therapeutics Inc. $19.9108/10/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 855027591 CMS
Amarin Pharma Inc. $17.8108/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 815303803 CMS
SANOFI-AVENTIS U.S. LLC $15.3708/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 843484733 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $20.3608/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 850045073 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $10.8208/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 850325719 CMS
Medtronic, Inc. $9.2708/05/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 827391407 CMS
Bayer HealthCare Pharmaceuticals Inc. $20.0608/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 789174143 CMS
Medtronic, Inc. $121.0908/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 827391397 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $12,938.13 199
PY2020 $5,752.64 226
PY2021 $10,858.18 245
PY2022 $18,329.25 254
PY2023 $12,095.18 234
PY2024 $6,110.46 194
PY2025 $6,823.51 236

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Recipient $1,496.03 7
PY2025 Principal investigator $356,936.74 60
PY2024 Recipient $1,696.56 8
PY2024 Principal investigator $179,185.78 21
PY2023 Principal investigator $104,194.28 3
PY2022 Principal investigator $8,418.12 3
PY2021 Recipient $1,946.41 12
PY2021 Principal investigator $65,090.09 38
PY2020 Recipient $7,410.57 3
PY2020 Principal investigator $137,779.79 40
PY2019 Recipient $5,813.94 10
PY2019 Principal investigator $209,008.80 46

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

67 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ABBVIE INC. $5,520.00 12/31/2025 Non-covered Recipient Entity
NOLA CARE CLINICAL RESEARCH LLC
A Phase 2/3 multicenter, double blinded, randomized, dose-conversion, active control study examining the efficacy and safety of Armour Thyroid compared to synthetic T4 for the treatment of adults with primary hypothyroidism No dispute reported 06/30/2026 1202534711
Principal investigator 1 Genentech, Inc. $4,880.00 12/19/2025 Non-covered Recipient Entity
NOLA CARES CLINICAL RESEARCH CENTER
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211629838
Principal investigator 1 RECORDATI_RARE_DISEASES_INC. $6,695.26 12/12/2025 Non-covered Recipient Entity
NOLA CARE
PAS576 No dispute reported 06/30/2026 1192299593
Principal investigator 1 ABBVIE INC. $6,504.30 12/05/2025 Non-covered Recipient Entity
NOLA CARE CLINICAL RESEARCH LLC
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202529316
Principal investigator 1 Genentech, Inc. $12,298.00 12/04/2025 Non-covered Recipient Entity
NOLA CARES CLINICAL RESEARCH CENTER
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211629843
Principal investigator 1 Genentech, Inc. $1,952.00 11/20/2025 Non-covered Recipient Entity
NOLA CARES CLINICAL RESEARCH CENTER
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211629826
Principal investigator 1 Genentech, Inc. $1,952.00 11/14/2025 Non-covered Recipient Entity
NOLA CARES CLINICAL RESEARCH CENTER
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211629834
Principal investigator 1 Genentech, Inc. $4,974.00 11/07/2025 Non-covered Recipient Entity
NOLA CARES CLINICAL RESEARCH CENTER
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211629830
Principal investigator 1 RECORDATI_RARE_DISEASES_INC. $8,460.68 11/07/2025 Non-covered Recipient Entity
NOLA CARE
PAS576 No dispute reported 06/30/2026 1192299587
Principal investigator 1 ABBVIE INC. $8,348.40 11/05/2025 Non-covered Recipient Entity
NOLA CARE CLINICAL RESEARCH LLC
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202521883
Principal investigator 1 Genentech, Inc. $4,709.00 10/29/2025 Non-covered Recipient Entity
NOLA CARES CLINICAL RESEARCH CENTER
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211629818
Principal investigator 1 Genentech, Inc. $1,952.00 10/23/2025 Non-covered Recipient Entity
NOLA CARES CLINICAL RESEARCH CENTER
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211629806
Principal investigator 1 Genentech, Inc. $2,928.00 10/16/2025 Non-covered Recipient Entity
NOLA CARES CLINICAL RESEARCH CENTER
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211629823
Principal investigator 1 ABBVIE INC. $11,254.95 10/09/2025 Non-covered Recipient Entity
NOLA CARE CLINICAL RESEARCH LLC
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202514705
Principal investigator 1 Genentech, Inc. $3,998.00 10/09/2025 Non-covered Recipient Entity
NOLA CARES CLINICAL RESEARCH CENTER
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211629810
Principal investigator 1 Genentech, Inc. $3,733.00 10/03/2025 Non-covered Recipient Entity
NOLA CARES CLINICAL RESEARCH CENTER
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211629814
Principal investigator 1 RECORDATI_RARE_DISEASES_INC. $23,249.94 09/25/2025 Non-covered Recipient Entity
NOLA CARE
PAS576 No dispute reported 06/30/2026 1192299549
Principal investigator 1 Genentech, Inc. $2,928.00 09/23/2025 Non-covered Recipient Entity
NOLA CARES CLINICAL RESEARCH CENTER
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211629791
Principal investigator 1 RECORDATI_RARE_DISEASES_INC. $98.22 09/22/2025 Non-covered Recipient Entity
NOLA CARE
PAS576 No dispute reported 06/30/2026 1192299543
Principal investigator 1 RECORDATI_RARE_DISEASES_INC. $214.23 09/22/2025 Non-covered Recipient Entity
NOLA CARE
PAS576 No dispute reported 06/30/2026 1192299545
Principal investigator 1 Genentech, Inc. $9,904.00 09/18/2025 Non-covered Recipient Entity
NOLA CARES CLINICAL RESEARCH CENTER
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211629802
Principal investigator 1 Genentech, Inc. $4,508.00 09/12/2025 Non-covered Recipient Entity
NOLA CARES CLINICAL RESEARCH CENTER
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211629787
Principal investigator 1 RECORDATI_RARE_DISEASES_INC. $2,329.16 09/05/2025 Non-covered Recipient Entity
NOLA CARE
PAS576 No dispute reported 06/30/2026 1192299535
Principal investigator 1 ABBVIE INC. $4,141.80 09/04/2025 Non-covered Recipient Entity
NOLA CARE CLINICAL RESEARCH LLC
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202509612
Principal investigator 1 Genentech, Inc. $1,952.00 09/04/2025 Non-covered Recipient Entity
NOLA CARES CLINICAL RESEARCH CENTER
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211629799
Principal investigator 1 Genentech, Inc. $6,400.00 08/26/2025 Non-covered Recipient Entity
NOLA CARES CLINICAL RESEARCH CENTER
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211629782
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $5,410.00 08/15/2025 Non-covered Recipient Entity
Nola Care Clinical Research
BAY 948862, A parallel-group treatment, Phase 2, double-blind, three-arm study to assess efficacy and safety of finerenone plus empagliflozin compared with either finerenone or empagliflozin in partic No dispute reported 06/30/2026 1225408650
Principal investigator 1 Genentech, Inc. $4,880.00 08/14/2025 Non-covered Recipient Entity
NOLA CARES CLINICAL RESEARCH CENTER
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211629795
Principal investigator 1 ABBVIE INC. $7,630.20 08/06/2025 Non-covered Recipient Entity
NOLA CARE CLINICAL RESEARCH LLC
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202503477
Principal investigator 1 Genentech, Inc. $4,538.00 07/22/2025 Non-covered Recipient Entity
NOLA CARES CLINICAL RESEARCH CENTER
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211629779
Principal investigator 1 RECORDATI_RARE_DISEASES_INC. $1,167.01 07/18/2025 Non-covered Recipient Entity
NOLA CARE
PAS576 No dispute reported 06/30/2026 1192299519
Principal investigator 1 Genentech, Inc. $5,856.00 07/10/2025 Non-covered Recipient Entity
NOLA CARES CLINICAL RESEARCH CENTER
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211629775
Principal investigator 1 ABBVIE INC. $14,594.85 07/02/2025 Non-covered Recipient Entity
NOLA CARE CLINICAL RESEARCH LLC
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202494301
Principal investigator 1 F. Hoffmann-La Roche AG $6,698.00 06/19/2025 Non-covered Recipient Entity
NOLA CARES CLINICAL RESEARCH CENTER
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211629748
Principal investigator 1 F. Hoffmann-La Roche AG $350.00 06/12/2025 Non-covered Recipient Entity
NOLA CARES CLINICAL RESEARCH CENTER
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211629723
Principal investigator 1 F. Hoffmann-La Roche AG $75.00 06/12/2025 Non-covered Recipient Entity
NOLA CARES CLINICAL RESEARCH CENTER
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211629728
Principal investigator 1 F. Hoffmann-La Roche AG $1,200.00 06/12/2025 Non-covered Recipient Entity
NOLA CARES CLINICAL RESEARCH CENTER
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211629733
Principal investigator 1 F. Hoffmann-La Roche AG $3,696.00 06/12/2025 Non-covered Recipient Entity
NOLA CARES CLINICAL RESEARCH CENTER
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211629736
Principal investigator 1 F. Hoffmann-La Roche AG $5,400.00 06/12/2025 Non-covered Recipient Entity
NOLA CARES CLINICAL RESEARCH CENTER
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211629740
Principal investigator 1 F. Hoffmann-La Roche AG $2,978.00 06/12/2025 Non-covered Recipient Entity
NOLA CARES CLINICAL RESEARCH CENTER
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211629744
Principal investigator 1 F. Hoffmann-La Roche AG $1,966.00 06/12/2025 Non-covered Recipient Entity
NOLA CARES CLINICAL RESEARCH CENTER
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211629752
Principal investigator 1 F. Hoffmann-La Roche AG $7,392.00 06/12/2025 Non-covered Recipient Entity
NOLA CARES CLINICAL RESEARCH CENTER
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211629755
Principal investigator 1 F. Hoffmann-La Roche AG $4,112.00 06/12/2025 Non-covered Recipient Entity
NOLA CARES CLINICAL RESEARCH CENTER
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211629760
Principal investigator 1 F. Hoffmann-La Roche AG $175.00 06/12/2025 Non-covered Recipient Entity
NOLA CARES CLINICAL RESEARCH CENTER
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211629771
Principal investigator 1 RECORDATI_RARE_DISEASES_INC. $7,418.80 06/12/2025 Non-covered Recipient Entity
NOLA CARE
PAS576 No dispute reported 06/30/2026 1192299501
Principal investigator 1 ABBVIE INC. $6,774.30 06/03/2025 Non-covered Recipient Entity
NOLA CARE CLINICAL RESEARCH LLC
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202488043
Principal investigator 1 F. Hoffmann-La Roche AG $8,040.00 05/27/2025 Non-covered Recipient Entity
NOLA CARES CLINICAL RESEARCH CENTER
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211629766
Principal investigator 1 ABBVIE INC. $15,022.80 05/07/2025 Non-covered Recipient Entity
NOLA CARE CLINICAL RESEARCH LLC
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202483713
Recipient Corcept Therapeutics $39.23 05/02/2025 Covered Recipient Physician COR311 No dispute reported 06/30/2026 1214163367
Recipient Corcept Therapeutics $71.74 05/02/2025 Covered Recipient Physician COR311 No dispute reported 06/30/2026 1214163375
Recipient Corcept Therapeutics $76.44 05/02/2025 Covered Recipient Physician COR311 No dispute reported 06/30/2026 1214163379
Recipient Corcept Therapeutics $98.62 05/02/2025 Covered Recipient Physician COR311 No dispute reported 06/30/2026 1214163384
Recipient Corcept Therapeutics $32.67 05/02/2025 Covered Recipient Physician COR311 No dispute reported 06/30/2026 1214163388
Recipient Corcept Therapeutics $669.96 05/01/2025 Covered Recipient Physician COR311 No dispute reported 06/30/2026 1214163364
Recipient Corcept Therapeutics $507.37 05/01/2025 Covered Recipient Physician COR311 No dispute reported 06/30/2026 1214163372
Principal investigator 1 RECORDATI_RARE_DISEASES_INC. $2,000.00 04/24/2025 Non-covered Recipient Entity
NOLA CARE
PAS576 No dispute reported 06/30/2026 1192299479
Principal investigator 1 RECORDATI_RARE_DISEASES_INC. $15,000.00 04/24/2025 Non-covered Recipient Entity
NOLA CARE
PAS576 No dispute reported 06/30/2026 1192299481
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $1,006.00 03/19/2025 Non-covered Recipient Entity
Nola Care Clinical Research
BAY 948862, A parallel-group treatment, Phase 2, double-blind, three-arm study to assess efficacy and safety of finerenone plus empagliflozin compared with either finerenone or empagliflozin in participants with chronic kidney disease and type 2 diabetes No dispute reported 06/30/2026 1225405686
Principal investigator 1 ABBVIE INC. $3,148.20 03/07/2025 Non-covered Recipient Entity
NOLA CARE CLINICAL RESEARCH LLC
M21-341 - A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202460524
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $2,868.00 02/21/2025 Non-covered Recipient Entity
Nola Care Clinical Research
BAY 948862, A parallel-group treatment, Phase 2, double-blind, three-arm study to assess efficacy and safety of finerenone plus empagliflozin compared with either finerenone or empagliflozin in participants with chronic kidney disease and type 2 diabetes No dispute reported 06/30/2026 1225407142
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $3,446.00 02/19/2025 Non-covered Recipient Entity
Nola Care Clinical Research
BAY 948862, A parallel-group treatment, Phase 2, double-blind, three-arm study to assess efficacy and safety of finerenone plus empagliflozin compared with either finerenone or empagliflozin in participants with chronic kidney disease and type 2 diabetes No dispute reported 06/30/2026 1225407192
Principal investigator 1 ABBVIE INC. $699.30 02/06/2025 Non-covered Recipient Entity
NOLA CARE CLINICAL RESEARCH LLC
M21-341 - A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202448354
Principal investigator 1 F. Hoffmann-La Roche AG $20,000.00 02/05/2025 Non-covered Recipient Entity
NOLA CARES CLINICAL RESEARCH CENTER
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211629715
Principal investigator 1 F. Hoffmann-La Roche AG $2,500.00 02/05/2025 Non-covered Recipient Entity
NOLA CARES CLINICAL RESEARCH CENTER
CT-388-104 OW/OB with T2D No dispute reported 06/30/2026 1211629720
Principal investigator 1 Bayer Healthcare Pharmaceuticals Inc. $255.74 01/31/2025 Non-covered Recipient Entity
Nola Care Clinical Research
BAY 948862, A parallel-group treatment, Phase 2, double-blind, three-arm study to assess efficacy and safety of finerenone plus empagliflozin compared with either finerenone or empagliflozin in partic No dispute reported 06/30/2026 1225411832
Principal investigator 1 Novartis Pharmaceuticals Corporation $44,055.30 01/27/2025 Non-covered Recipient Entity
NOLA CARE CLINICAL RESEARCH
A Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate the Effect of Inclisiran on Preventing Major Adverse Cardiovascular Events in High-risk Primary Prevention Patients (VICTORION-1 PREVENT) No dispute reported 06/30/2026 1190312465
Principal investigator 1 ABBVIE INC. $699.30 01/02/2025 Non-covered Recipient Entity
NOLA CARE CLINICAL RESEARCH LLC
M21-341 - A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants No dispute reported 06/30/2026 1202434828